NADPH (tetracyclohexanamine)

CAS No. 100929-71-3

NADPH (tetracyclohexanamine)( —— )

Catalog No. M22481 CAS No. 100929-71-3

NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 50 In Stock
25MG 91 In Stock
50MG 146 In Stock
100MG 219 In Stock
200MG 328 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NADPH (tetracyclohexanamine)
  • Note
    Research use only, not for human use.
  • Brief Description
    NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.
  • Description
    NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Ferroptosis
  • Recptor
    Ferroptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100929-71-3
  • Formula Weight
    1142.12
  • Molecular Formula
    C45H82N11O17P3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:100 mg/mL (87.56 mM);DMSO:84 mg/mL (73.55 mM)
  • SMILES
    NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • UAMC-3203

    UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.

  • Cerivastatin sodium

    Cerivastatin sodium (BAY W 6228 sodium) is an orally active and highly potent HMG-CoA reductase inhibitor with lipid-lowering activity that can reduce low-density lipoprotein cholesterol levels.

  • PRLX-93936 HCL

    PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.